Yang H - Search Results

1

A review of structural modification and biological activities of oleanolic acid.

Yang H, Deng M, Jia H, Zhang K, Liu Y, Cheng M, Xiao W. Yang H, et al. Chin J Nat Med. 2024 Jan;22(1):15-30. doi: 10.1016/S1875-5364(24)60559-5. Chin J Nat Med. 2024. PMID: 38278556 Review.

2

Graphene Oxide Foam Supported Titanium(IV): Recoverable Heterogeneous Catalyst for Efficient, Selective Oxidation of Arylalkyl Sulfides to Sulfoxides Under Mild Conditions.

Wang Q, Ma W, Tong Q, Du G, Wang J, Zhang M, Jiang H, Yang H, Liu Y, Cheng M. Wang Q, et al. Among authors: yang h. Sci Rep. 2017 Aug 3;7(1):7209. doi: 10.1038/s41598-017-07590-1. Sci Rep. 2017. PMID: 28775258 Free PMC article.

3

Optimization of WZ4003 as NUAK inhibitors against human colorectal cancer.

Yang H, Wang X, Wang C, Yin F, Qu L, Shi C, Zhao J, Li S, Ji L, Peng W, Luo H, Cheng M, Kong L. Yang H, et al. Eur J Med Chem. 2021 Jan 15;210:113080. doi: 10.1016/j.ejmech.2020.113080. Epub 2020 Dec 4. Eur J Med Chem. 2021. PMID: 33310286

4

Synthesis, Molecular Docking Analysis, and Biological Evaluations of Saccharide-Modified Sulfonamides as Carbonic Anhydrase IX Inhibitors.

Zhang Z, Yang H, Zhong Y, Wang Y, Wang J, Cheng M, Liu Y. Zhang Z, et al. Among authors: yang h. Int J Mol Sci. 2021 Dec 19;22(24):13610. doi: 10.3390/ijms222413610. Int J Mol Sci. 2021. PMID: 34948406 Free PMC article.

5

Design, synthesis, and biological evaluation of novel pyrazolo [3,4-d]pyrimidine derivatives as potent PLK4 inhibitors for the treatment of TRIM37-amplified breast cancer.

Sun Y, Sun Y, Wang L, Wu T, Yin W, Wang J, Xue Y, Qin Q, Sun Y, Yang H, Zhao D, Cheng M. Sun Y, et al. Among authors: yang h. Eur J Med Chem. 2022 Aug 5;238:114424. doi: 10.1016/j.ejmech.2022.114424. Epub 2022 May 10. Eur J Med Chem. 2022. PMID: 35576702

6

Structure-based discovery of 1-(3-fluoro-5-(5-(3-(methylsulfonyl)phenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)phenyl)-3-(pyrimidin-5-yl)urea as a potent and selective nanomolar type-II PLK4 inhibitor.

Sun Y, Wang L, Sun Y, Wang J, Xue Y, Wu T, Yin W, Qin Q, Sun Y, Wang H, Gao Y, Yang H, Zhao D, Cheng M. Sun Y, et al. Among authors: yang h. Eur J Med Chem. 2022 Dec 5;243:114714. doi: 10.1016/j.ejmech.2022.114714. Epub 2022 Aug 30. Eur J Med Chem. 2022. PMID: 36063666

7

Design, synthesis and antitumor activity evaluation of novel indole acrylamide derivatives as IMPDH inhibitors.

Jia HW, Yang HL, Xiong ZL, Deng MH, Wang T, Liu Y, Cheng M. Jia HW, et al. Bioorg Chem. 2022 Dec;129:106213. doi: 10.1016/j.bioorg.2022.106213. Epub 2022 Oct 21. Bioorg Chem. 2022. PMID: 36308854

8

Collective Total Syntheses of Benzo[c]phenanthridine Alkaloids via a Sequential Transition Metal-Catalyzed Pot-Economic Approach.

Fu J, Li B, Wang X, Wang H, Deng M, Yang H, Lin B, Cheng M, Yang L, Liu Y. Fu J, et al. Among authors: yang l, yang h. Org Lett. 2022 Nov 18;24(45):8310-8315. doi: 10.1021/acs.orglett.2c03278. Epub 2022 Nov 7. Org Lett. 2022. PMID: 36342358

9

Identification of Novel Artemisinin Hybrids Induce Apoptosis and Ferroptosis in MCF-7 Cells.

Zhong Y, Li ZN, Jiang XY, Tian X, Deng MH, Cheng MS, Yang HL, Liu Y. Zhong Y, et al. Int J Mol Sci. 2022 Dec 12;23(24):15768. doi: 10.3390/ijms232415768. Int J Mol Sci. 2022. PMID: 36555409 Free PMC article.

10

Discovery of CZS-241: A Potent, Selective, and Orally Available Polo-Like Kinase 4 Inhibitor for the Treatment of Chronic Myeloid Leukemia.

Sun Y, Xue Y, Liu H, Mu S, Sun P, Sun Y, Wang L, Wang H, Wang J, Wu T, Yin W, Qin Q, Sun Y, Yang H, Zhao D, Cheng M. Sun Y, et al. Among authors: yang h. J Med Chem. 2023 Feb 23;66(4):2396-2421. doi: 10.1021/acs.jmedchem.2c02124. Epub 2023 Feb 3. J Med Chem. 2023. PMID: 36734825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56,663 results

Search Page